Back to top
more

Canopy Growth (CGC)

(Delayed Data from NSDQ)

$1.10 USD

1.10
4,775,469

+0.05 (4.76%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $1.10 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (173 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Canopy Growth (CGC) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in fiscal third quarter.

Zacks Equity Research

Canopy Growth Corporation (CGC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Canopy Growth Corporation (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sweta Killa headshot

Cannabis ETF Tops in January: 5 Stocks That Led the Way

by Sweta Killa

Inside the top performing stocks in the top ETF of January.

Zacks Equity Research

Canopy Growth Corporation (CGC) Stock Moves -0.64%: What You Should Know

by Zacks Equity Research

In the latest trading session, Canopy Growth Corporation (CGC) closed at $40.07, marking a -0.64% move from the previous day.

Sanghamitra Saha headshot

Investing Strategies to Follow on Democratic Senate and House

by Sanghamitra Saha

Democratic taking control of both House and Senate, these investing strategies should prosper in the coming days.

Zacks Equity Research

The Zacks Analyst Blog Highlights: IIPR, CRON, CGC and STZ

by Zacks Equity Research

The Zacks Analyst Blog Highlights: IIPR, CRON, CGC and STZ

Nitish Marwah headshot

4 Stocks to Ride the Wave of Cannabis Legalization

by Nitish Marwah

Increasing tolerance, financial protection, credit availability, and legal votes have shaped America's hemp industry lately.

Zacks Equity Research

Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) closed the most recent trading day at $25.54, moving -1.66% from the previous trading session.

Sweta Killa headshot

ETFs to Buy as Tilray-Aphria Merger Creates Cannabis Giant

by Sweta Killa

Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.

Neena Mishra headshot

Should You Buy Cannabis Stocks & ETFs Now?

by Neena Mishra

CNBC's cannabis expert Tim Seymour discusses the recent developments in the space.

Zacks Equity Research

Company News for Nov 10, 2020

by Zacks Equity Research

Companies In The News Are: MCD, GSK, PRTY, CGC

Zacks Equity Research

Should You Buy Canopy Growth (CGC) Ahead of Earnings?

by Zacks Equity Research

Canopy Growth (CGC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

Canopy Growth (CGC) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in fiscal second quarter.

Trina Mukherjee headshot

3 Medical Product Stocks Poised to Beat This Earnings Season

by Trina Mukherjee

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, on the back of several factors.

Neena Mishra headshot

Why Cannabis Stocks & ETFs Are Soaring

by Neena Mishra

Marijuana stocks are rising on hopes of favorable regulatory environment

Zacks Equity Research

Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Cardinal Health's (CAH) fiscal first-quarter results are likely to reflect solid performance in Pharmaceutical segment.

Zacks Equity Research

What's in Store for Becton, Dickinson's (BDX) Q4 Earnings?

by Zacks Equity Research

Becton, Dickinson's (BDX) fiscal fourth-quarter results likely to reflect robust performance at BD Life Sciences.

Zacks Equity Research

Humana (HUM) Gears Up for Q3 Earnings: What Awaits the Stock?

by Zacks Equity Research

Humana's (HUM) third-quarter 2020 results are likely to reflect elevated expenses and lower net investment income, partially offset by a growing membership base.

Zacks Equity Research

Universal Health (UHS) to Report Q3 Results: What to Expect

by Zacks Equity Research

Universal Health's (UHS) third-quarter earnings results are likely to reflect depressed revenues and weak admissions.

Zacks Equity Research

Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues

by Zacks Equity Research

Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.

Zacks Equity Research

Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.

Zacks Equity Research

Tenet Healthcare's (THC) Earnings Beat in Q3, Improve Y/Y

by Zacks Equity Research

Tenet Healthcare's (THC) third-quarter earnings gain from the Ambulatory segment and lower expenses.

Zacks Equity Research

Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands

by Zacks Equity Research

Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands

Tracey Ryniec headshot

Is it Finally Time to Buy Marijuana Stocks?

by Tracey Ryniec

With new states set to legalize cannabis this November, and the possibility of federal legalization looming, will the marijuana stocks finally live up to the hype?

Zacks Equity Research

Canopy Growth (CGC) Looks Good: Stock Adds 8.5% in Session

by Zacks Equity Research

Canopy Growth (CGC) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.